Cytori meldt aangehouden voordelen na 18 maanden in proef met hartceltherapie na hartaanval
08 juin 2011 06h00 HE
|
Cytori Therapeutics
SAN DIEGO, CA--(Marketwire - Jun 8, 2011) - Cytori Therapeutics (NASDAQ: CYTX) meldt resultaten na 18 maanden van APOLLO-onderzoek voor Acuut Myocardiaal Infarct (AMI). De resultaten van de 14...
Cytori rende noti i notevoli benefici a 18 mesi registrati nel suo studio sugli attacchi di cuore basato sulla terapia con cellule per le patologie cardiache
08 juin 2011 06h00 HE
|
Cytori Therapeutics
SAN DIEGO, CA--(Marketwire - Jun 8, 2011) - Cytori Therapeutics (NASDAQ: CYTX) annuncia gli outcome a 18 mesi del suo studio APOLLO sull’infarto acuto del miocardio (AMI). I risultati dello...
Cytori informa sobre beneficios continuos a los 18 meses en un estudio de terapia celular cardiaca en ataques al corazón
08 juin 2011 06h00 HE
|
Cytori Therapeutics
SAN DIEGO, CA--(Marketwire - Jun 8, 2011) - Cytori
Therapeutics (NASDAQ: CYTX) da a
conocer los resultados a los 18 meses de su estudio clínico APOLLO sobre infartos agudos de
miocardio (IAM). Los...
Cytori annonce des avantages significatifs à 18 mois dans l’essai sur le traitement des crises cardiaques par la thérapie cellulaire cardiaque
08 juin 2011 06h00 HE
|
Cytori Therapeutics
SAN DIEGO, CA--(Marketwire - Jun 8, 2011) - Cytori Therapeutics (NASDAQ: CYTX) annonce les résultats à 18 mois de son essai APOLLO pour l'infarctus aigu du myocarde (IAM). Les résultats de l'essai...
Cytori Receives Cell-Enriched Fat Grafting Patent in Japan
02 juin 2011 08h00 HE
|
Cytori Therapeutics, Inc.
SAN DIEGO, CA--(Marketwire - Jun 2, 2011) - Cytori Therapeutics (NASDAQ: CYTX) has received Japanese Patent No. 4722041 (the '041 patent) covering the preparation of adipose-derived stem and...
NHS National Innovation Centre Identifies Celution(R) as Cost-Effective Innovative Technology for Partial Breast Reconstruction
31 mai 2011 06h00 HE
|
Cytori Therapeutics, Inc.
ZUG, SWITZERLAND--(Marketwire - May 31, 2011) - Cytori Therapeutics, Inc. (NASDAQ: CYTX) today announced that results from an economic analysis carried out by the UK NHS National Innovation Centre...
Urinary Incontinence Study Using the Celution(R) System Approved in Japan
25 mai 2011 09h00 HE
|
Cytori Therapeutics, Inc.
SAN DIEGO, CA--(Marketwire - May 25, 2011) - Cytori Therapeutics (NASDAQ: CYTX) has learned that the Japanese Ministry of Health, Labor and Welfare ("MHLW"), the Japanese health regulatory body, has...
Cytori to Present at the Jefferies 2011 Global Healthcare Conference on June 8
24 mai 2011 08h00 HE
|
Cytori Therapeutics, Inc.
SAN DIEGO, CA--(Marketwire - May 24, 2011) - Cytori Therapeutics (NASDAQ: CYTX) will present and provide a corporate update from the Jefferies 2011 Global Healthcare Conference on Wednesday, June 8,...
Cytori Announces Clyde W. Shores as Executive Vice President of Marketing & Sales
06 mai 2011 07h00 HE
|
Cytori Therapeutics, Inc.
SAN DIEGO, CA--(Marketwire - May 6, 2011) - Cytori Therapeutics (NASDAQ: CYTX) has appointed Clyde W. Shores as Executive Vice President of Marketing & Sales where he will lead the Company's...
Cytori Provides Update on Product Pipeline Developments and Reports First Quarter Results
05 mai 2011 16h05 HE
|
Cytori Therapeutics, Inc.
SAN DIEGO, CA--(Marketwire - May 5, 2011) - Cytori Therapeutics, Inc. (NASDAQ: CYTX)
provides a quarterly update on its development pipeline and reports
financial results for the first quarter of...